Therapeutic drug monitoring of amikacin in septic patients
Clicks: 405
ID: 267481
2013
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
405 views
67 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #3 of 7 articles by views in critical care (london, england)
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
TDM resulted in adjustment of AMK therapy in most of our septic patients. Early achievement of an optimal Cpeak/MIC ratio may have an impact on clinical and microbiological responses, but not on outcome. In patients with impaired renal function prior to treatment, AMK therapy may be associated with …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (49 words).
Try re-searching for a better abstract.
| Reference Key |
w2013criticaltherapeutic
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Duszynska W;Taccone FS;Hurkacz M;Kowalska-Krochmal B;Wiela-Hojeńska A;Kübler A;; |
| Journal | critical care (london, england) |
| Year | 2013 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
adult
female
male
aged
middle aged
sepsis / drug therapy*
dose-response relationship
drug
anti-bacterial agents / therapeutic use*
amikacin / therapeutic use*
anti-bacterial agents / blood
pmid:23886243
pmc4057344
doi:10.1186/cc12844
wieslawa duszynska
fabio silvio taccone
andrzej kübler
amikacin / blood
critical illness / therapy*
drug monitoring / methods*
metabolic clearance rate / physiology
sepsis / blood
sepsis / diagnosis
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.